Inherited bone marrow failure syndromes support services contract

Ended Definitive Contract Awarded Last action

Contract number
HHSN261201700004C
Awardee
Awarding agency
Obligated
$4,284,210

Award facts

Opportunity
Contract value 69% obligated
$6,202,649.67 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Rockville, MD 20850, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00018 -$6,141
Funding Only Action P00017 · DE-obligate FY18 funding -$10,925
Funding Only Action P00016 $50,000
Exercise an Option P00015 $150,000
Funding Only Action P00014 $162,175
Funding Only Action P00013 $260,000
Exercise an Option P00012 $500,000
Funding Only Action P00011 $250,000
Funding Only Action P00010 $400,000
Exercise an Option P00009 $360,000
Funding Only Action P00008 $650,000
Exercise an Option P00007 $180,000
Funding Only Action P00006 $180,000
Funding Only Action 5 $150,000
Funding Only Action 4 $180,000
Exercise an Option 3 $229,101
Funding Only Action 2 $300,000
Funding Only Action 1 $150,000
Original award $150,000
Show all 19

About this award

Written by GovTribe AI ·

The National Cancer Institute awarded a definitive contract to Westat, Inc. for inherited bone marrow failure syndromes support services on January 1, 2017, with a ceiling value of $6.2 million and ultimate completion date of June 30, 2022.

The contract is priced on a cost-plus-fixed-fee basis with no set-aside. Place of performance is Rockville, MD.

Service Contract Inventory reporting shows government-paid invoicing of $2.7 million across FY2018–FY2022, declining from $1 million in FY2021 (4.1 FTEs, 8,457 contractor hours at $123.18/hr) to $451 thousand in FY2022 (3.2 FTEs, 6,726 contractor hours at $66.99/hr). The awardee self-performed all reported hours with no subcontractor engagement.

Quick answers

Who was awarded contract HHSN261201700004C?

HHSN261201700004C was awarded to Westat, Inc. by National Cancer Institute (National Institutes of Health) on January 1, 2017.

How much is contract HHSN261201700004C worth?

The government has obligated $4,284,210 on HHSN261201700004C. Its current value, with exercised options, is $6,202,650.

Was contract HHSN261201700004C competed?

The extent of competition for HHSN261201700004C was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login